|
VEZF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.921900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.856100E-03 |
| Normal-vs-Stage2 |
1.460380E-01 |
| Normal-vs-Stage3 |
2.807800E-02 |
| Normal-vs-Stage4 |
3.466800E-01 |
| Stage1-vs-Stage2 |
9.601800E-01 |
| Stage1-vs-Stage3 |
5.663600E-01 |
| Stage1-vs-Stage4 |
9.977400E-01 |
| Stage2-vs-Stage3 |
6.895800E-01 |
| Stage2-vs-Stage4 |
9.716400E-01 |
| Stage3-vs-Stage4 |
7.251000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.466340E-02 |
| Normal-vs-AfricanAmerican |
2.701900E-03 |
| Normal-vs-Asian |
2.1389999999899E-05 |
| Caucasian-vs-AfricanAmerican |
3.634200E-01 |
| Caucasian-vs-Asian |
2.822400E-03 |
| AfricanAmerican-vs-Asian |
7.414000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.829700E-04 |
| Normal-vs-Female |
9.356200E-01 |
| Male-vs-Female |
1.413790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.176260E-02 |
| Normal-vs-Extreme_Weight |
1.956130E-03 |
| Normal-vs-Obese |
2.893400E-01 |
| Normal-vs-Extreme_Obese |
6.032800E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.956000E-01 |
| Normal_Weight-vs-Obese |
1.377180E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.500200E-01 |
| Extreme_Weight-vs-Obese |
8.834300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.448000E-01 |
| Obese-vs-Extreme_Obese |
8.823900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.686000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.653000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.01970000000596E-05 |
| Normal-vs-Age(81-100Yrs) |
4.536700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.136800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.764200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.847800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.050010E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.707900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.948440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.081800E-02 |
| Normal-VS-Type2 PRCC |
4.93629999998024E-06 |
| Normal-VS-KIRP CIMP |
8.171200E-01 |
| Normal-VS-Unclassified PRCC |
7.702800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.120300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.315600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.198800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.436000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.594000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.079200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70399999946491E-07 |
| Normal-vs-N1 |
4.648400E-01 |
| Normal-vs-N2 |
9.403200E-01 |
| N0-vs-N1 |
6.680100E-02 |
| N0-vs-N2 |
3.051000E-01 |
| N1-vs-N2 |
7.137000E-01 |
|
|
